OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 67 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $15,608,000 | +44.0% | 821,457 | +2.3% | 0.00% | – |
| Q4 2018 | $10,840,000 | +36.6% | 802,978 | +12.3% | 0.00% | – |
| Q3 2018 | $7,936,000 | +123.9% | 715,016 | -0.9% | 0.00% | – |
| Q4 2016 | $3,544,000 | -1.5% | 721,743 | -0.5% | 0.00% | – |
| Q3 2016 | $3,599,000 | -1.4% | 725,617 | +1.2% | 0.00% | – |
| Q2 2016 | $3,650,000 | -11.3% | 717,152 | -0.4% | 0.00% | – |
| Q1 2016 | $4,113,000 | -43.2% | 720,354 | +3.2% | 0.00% | – |
| Q4 2015 | $7,245,000 | -41.9% | 697,976 | +3.4% | 0.00% | – |
| Q3 2015 | $12,471,000 | -0.8% | 675,210 | +4.5% | 0.00% | -100.0% |
| Q2 2015 | $12,571,000 | +10.5% | 645,994 | -0.1% | 0.00% | 0.0% |
| Q1 2015 | $11,373,000 | +13.9% | 646,961 | +3.6% | 0.00% | 0.0% |
| Q4 2014 | $9,983,000 | +29.3% | 624,370 | +1.8% | 0.00% | 0.0% |
| Q3 2014 | $7,719,000 | -15.6% | 613,123 | +4.7% | 0.00% | 0.0% |
| Q2 2014 | $9,143,000 | +18.4% | 585,332 | -0.5% | 0.00% | 0.0% |
| Q1 2014 | $7,725,000 | -12.3% | 588,372 | +7.4% | 0.00% | 0.0% |
| Q4 2013 | $8,813,000 | +2.6% | 548,087 | +6.2% | 0.00% | 0.0% |
| Q3 2013 | $8,587,000 | +61.9% | 516,019 | -2.0% | 0.00% | 0.0% |
| Q2 2013 | $5,304,000 | – | 526,692 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|